• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体肺重量:原发性移植肺功能障碍的一种新型预测指标。

Donor lung weight a novel predictor for primary graft dysfunction.

作者信息

Martinsson Andreas, Thoren Anders, Ricksten Sven-Erik, Oras Jonatan, Abed Moustafa Mohsen, Vestlund Petra, Magnusson Jesper M, Wallinder Andreas

机构信息

Department of Anaesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

JHLT Open. 2025 Apr 30;9:100271. doi: 10.1016/j.jhlto.2025.100271. eCollection 2025 Aug.

DOI:10.1016/j.jhlto.2025.100271
PMID:40520818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12166819/
Abstract

BACKGROUND

Primary graft dysfunction (PGD) remains a leading cause of early morbidity and mortality in lung transplantation. PGD is characterized by diffuse alveolar damage and the accumulation of extravascular lung water in the transplanted lung. Pre-existing injury and stress during the donation process are further aggravated by ischemia-reperfusion injury occurring during donation and transplantation. This study examines the relationship between adjusted donor lung weight, a surrogate for extravascular lung water, and outcomes following bilateral lung transplantation.

METHODS

We retrospectively analyzed 194 bilateral lung transplantations performed between January 2014 and May 2021. Donor lung weights were recorded after procurement, adjusted for body surface area, and categorized into quartiles. The primary outcomes assessed were the incidence of PGD (grades II and III) and duration of intensive care unit (ICU) stay. Secondary outcomes included mechanical ventilation duration, pulmonary function at discharge, and one-year mortality.

RESULTS

The incidence of PGD was significantly higher in the upper 4th quartile group ("high-weight," 22.9%) compared with the three lower quartile groups ("low-weight," 8.9%) ( = .020). Multivariate regression identified adjusted lung weight as an independent risk factor for PGD. The "low-weight" group showed higher rates of early extubation within 72 hours of lung transplantation (90.9% vs 83.0%,  = 0.048) and shorter ICU stays (median 3 vs 5 days,  = 0.026). No significant differences were found in ventilation duration, spirometry values, or 1-year survival.

CONCLUSION

Adjusted donor lung weight is an independent predictor of PGD, suggesting that higher lung weights contribute to worse early outcomes post-transplant. Incorporating lung weight into donor assessment may improve recipient management and outcomes.

摘要

背景

原发性移植肺功能障碍(PGD)仍然是肺移植早期发病和死亡的主要原因。PGD的特征是弥漫性肺泡损伤和移植肺血管外肺水积聚。捐赠过程中预先存在的损伤和应激会因捐赠和移植过程中发生的缺血再灌注损伤而进一步加重。本研究探讨了作为血管外肺水替代指标的调整后供肺重量与双侧肺移植术后结局之间的关系。

方法

我们回顾性分析了2014年1月至2021年5月期间进行的194例双侧肺移植病例。获取供肺后记录其重量,并根据体表面积进行调整,然后分为四分位数。评估的主要结局是PGD(II级和III级)的发生率和重症监护病房(ICU)住院时间。次要结局包括机械通气时间、出院时的肺功能和一年死亡率。

结果

与三个较低四分位数组(“低重量”组,8.9%)相比,上四分位数组(“高重量”组,22.9%)的PGD发生率显著更高(P = 0.020)。多因素回归分析确定调整后的肺重量是PGD的独立危险因素。“低重量”组在肺移植后72小时内的早期拔管率更高(90.9%对83.0%,P = 0.048),ICU住院时间更短(中位数3天对5天,P = 0.026)。在通气时间、肺量计值或1年生存率方面未发现显著差异。

结论

调整后的供肺重量是PGD的独立预测指标,表明较高的肺重量会导致移植后早期结局更差。将肺重量纳入供体评估可能会改善受体管理和结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/3949dcb5050d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/be3a63bb8d35/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/00030d885093/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/1b2e1d4ebb36/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/3949dcb5050d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/be3a63bb8d35/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/00030d885093/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/1b2e1d4ebb36/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb9/12166819/3949dcb5050d/gr4.jpg

相似文献

1
Donor lung weight a novel predictor for primary graft dysfunction.供体肺重量:原发性移植肺功能障碍的一种新型预测指标。
JHLT Open. 2025 Apr 30;9:100271. doi: 10.1016/j.jhlto.2025.100271. eCollection 2025 Aug.
2
Prioritizing direct heart procurement in organ donors after circulatory death does not jeopardize lung transplant outcomes.在循环性死亡后的器官捐献者中优先进行直接心脏获取不会危及肺移植结果。
JTCVS Tech. 2022 Oct 6;16:182-195. doi: 10.1016/j.xjtc.2022.08.032. eCollection 2022 Dec.
3
Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.再灌注后立即出现的移植物功能障碍可预测活体供体肺叶移植的短期预后,但对尸体肺移植则不然。
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):314-20. doi: 10.1093/icvts/ivv357. Epub 2015 Dec 23.
4
Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.单中心肺移植术后原发性移植肺功能障碍的危险因素及生存影响
Transplant Proc. 2012 Oct;44(8):2462-8. doi: 10.1016/j.transproceed.2012.07.134.
5
Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.口服吸入AP301治疗肺移植术后原发性移植物功能障碍:一项前瞻性随机试验研究。
J Heart Lung Transplant. 2017 Sep 30. doi: 10.1016/j.healun.2017.09.021.
6
Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.基于供体大小的肺保护性通气与肺移植后严重原发性移植物功能障碍的风险降低相关。
J Heart Lung Transplant. 2021 Oct;40(10):1212-1222. doi: 10.1016/j.healun.2021.06.016. Epub 2021 Jul 10.
7
Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.与脑死亡后捐献相比,心脏移植后循环死亡后捐献的严重原发性移植物功能障碍的预后改善。
J Card Fail. 2023 Jan;29(1):67-75. doi: 10.1016/j.cardfail.2022.10.429. Epub 2022 Nov 6.
8
Does Perfadex affect outcomes in clinical lung transplantation?Perfadex对临床肺移植的结果有影响吗?
J Heart Lung Transplant. 2005 Dec;24(12):2243-8. doi: 10.1016/j.healun.2005.06.019.
9
Ventilation parameters and early graft function in double lung transplantation.双肺移植中的通气参数与早期移植物功能。
J Heart Lung Transplant. 2021 Jan;40(1):4-11. doi: 10.1016/j.healun.2020.10.003. Epub 2020 Oct 13.
10
[Analysis of the correlation between driving pressure and prognosis in lung transplant recipients based on restricted cubic spline model].基于受限立方样条模型分析肺移植受者驱动压与预后的相关性
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Dec;36(12):1249-1255. doi: 10.3760/cma.j.cn121430-20240407-00311.

引用本文的文献

1
Primary Graft Dysfunction in Lung Transplantation: An Overview of the Molecular Mechanisms.肺移植中的原发性移植功能障碍:分子机制概述
Int J Mol Sci. 2025 Jul 15;26(14):6776. doi: 10.3390/ijms26146776.

本文引用的文献

1
Lung Transplantation.肺移植
N Engl J Med. 2024 Nov 14;391(19):1822-1836. doi: 10.1056/NEJMra2401039.
2
Real-time lung weight measurement during clinical ex vivo lung perfusion.临床离体肺灌注过程中的实时肺重量测量。
J Heart Lung Transplant. 2024 Dec;43(12):2008-2017. doi: 10.1016/j.healun.2024.06.013. Epub 2024 Jun 27.
3
The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.供体吸烟对肺移植后原发性移植物功能障碍和死亡率的影响。
Am J Respir Crit Care Med. 2024 Jan 1;209(1):91-100. doi: 10.1164/rccm.202303-0358OC.
4
Inspiratory and end-expiratory effects of lung recruitment in the prone position on dorsal lung aeration - new physiological insights in a secondary analysis of a randomised controlled study in post-cardiac surgery patients.俯卧位肺复张对背侧肺通气的吸气和呼气末影响——心脏手术后患者随机对照研究二次分析中的新生理见解
BJA Open. 2022 Nov 21;4:100105. doi: 10.1016/j.bjao.2022.100105. eCollection 2022 Dec.
5
Normothermic Regional Perfusion-The Next Frontier in Organ Transplants?常温区域灌注——器官移植的下一个前沿领域?
JAMA. 2023 Jun 27;329(24):2123-2124. doi: 10.1001/jama.2023.9294.
6
Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers.肺移植后的原发性移植肺功能障碍:从发病机制到未来前沿
World J Transplant. 2023 Mar 18;13(3):58-85. doi: 10.5500/wjt.v13.i3.58.
7
Organ Donation, the Non-Perfect Lung Donor, and Variability in Conversion to Transplant.器官捐赠、非完美肺供体与转化为移植的可变性。
Clin Chest Med. 2023 Mar;44(1):69-75. doi: 10.1016/j.ccm.2022.10.005.
8
Critical Care Management of the Lung Transplant Recipient.肺移植受者的重症监护管理。
Clin Chest Med. 2023 Mar;44(1):105-119. doi: 10.1016/j.ccm.2022.10.010.
9
Contemporary trends in PGD incidence, outcomes, and therapies.当代 PGD 发生率、结局和治疗的趋势。
J Heart Lung Transplant. 2022 Dec;41(12):1839-1849. doi: 10.1016/j.healun.2022.08.013. Epub 2022 Aug 31.
10
Current achievements and future applications of ex vivo lung perfusion; where do we go from here?体外肺灌注的当前成果与未来应用;我们将何去何从?
J Thorac Cardiovasc Surg. 2023 Mar;165(3):920-924. doi: 10.1016/j.jtcvs.2022.06.019. Epub 2022 Jul 4.